70 learners taking this course
What a time to be alive! In the past decade, there has been an explosion of the direct-to-consumer (DTC) genetic testing market. Companies like 23andMe, AncestryDNA, Gene by Gene, and Illumina are amassing significant popularity and awareness to the everyday person! What was once thousands of dollars and out of reach for the majority of people is now on average $100 or less. Available at big-box retail stores, as well as online, these genetic tests are just a cheek swab or test tube of spit away from a plethora of information about YOU!
While the information is certainly exciting and the health reports can be empowering, what about those unexpected findings that raise your eyebrows and your ethical dilemma flag? The ethical considerations range from surprise half-siblings, unexpected disease carrier information, finding criminals, compromised confidentiality, and many others. This course will examine the ethics of these popular direct-to-consumer genetic tests with the goal of helping you build an ethical framework around them.
- Define direct-to-consumer genetic testing
- Identify the pros and cons of direct-to-consumer genetic testing
- Identify ethical arguments both for and against direct-to-consumer genetic testing
- Develop ways to help patients navigate both anticipated and unexpected results
- Understand how direct-to-consumer genetic tests are regulated
- Understand when to implement the ethical principle of duty-to-warn